Stock ABERA ABERA BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Abera Bioscience AB

Equities

ABERA

SE0015245097

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.71 SEK -1.26% Intraday chart for Abera Bioscience AB -1.67% -8.72%
Feb. 09 Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Abera Bioscience AB is a Sweden-based company, which is active in biotechnology. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.

Number of employees: 6

Managers

Managers TitleAgeSince
Maria Alriksson CEO
 Chief Executive Officer 41 20-09-30
Joen Luirink FOU
 Founder 64 12-11-02
Mats Fredrik Lundgren CTO
 Chief Tech/Sci/R&D Officer 59 21-12-31

Members of the board

Members of the board TitleAgeSince
Ulla Cristina Glad BRD
 Director/Board Member 72 19-12-31
Leif Anders Gunnar Ericsson CHM
 Chairman 54 14-12-31
Joen Luirink FOU
 Founder 64 12-11-02
Fredrik Juserius BRD
 Director/Board Member 57 19-12-31
Florence Vicaire BRD
 Director/Board Member 53 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,463,462 8,370,568 ( 57.87 %) 0 57.87 %

Shareholders

NameEquities%Valuation
AIFM Capital AB
0.000000 %
0 0.000000 % - kr

Company contact information

Abera Bioscience AB

Dragarbrunnsgatan 45

751 47, Uppsala

+

http://www.aberabio.com
address Abera Bioscience AB(ABERA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ABERA BIOSCIENCE AB Stock Abera Bioscience AB
-8.72% 6.7M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.86B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.74B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ABERA Stock
  4. Company Abera Bioscience AB